State Pharmaceuticals Manufacturing Corporation

logo
Type
State Owned Enterprise
Industry
Health

The State Pharmaceuticals Manufacturing Corp is involved in the business of manufacturing, processing, stocking, packing, repacking and marketing of drugs. Its operations are divided into five segments: Production, Quality control, Formulation Research & Development, Marketing and Other Services. Its Production segment is involved in manufacturing pharmaceutical drugs and conducting initial and in-process testing of the products. The Quality Control (QC) Department is an independent internal regulatory body of the SPMC. Its overall function includes both Quality Control and monitoring of Quality assurance processes of the organisation by implementing a total quality management system and good manufacturing practices. The Formulation R&D segment is primarily involved in the development of new products and introducing them to the current manufacturing stream, and improving existing products. The Marketing segment distributes its drugs throughout its network and also abroad, to destinations including Egypt, Myanmar, Bangladesh and other countries. Other services include its Finance, Engineering and Audit departments. Established in 1987, its headquarters are in Ratmalana, Sri Lanka.

ROA
8.9
Governance
45.8
Profits/Losses
LKR 1,164,000

Governance Indicators

A systematic measure of how well this SOE is managed.

2019

Year of the most recent Annual Report available online

1

Have Annual Reports for the last five years been tabled in Parliament?

1

Does the Annual Report include the mandatory provisions set out in the PED guidelines?

1

Is the Audit Clean / Qualified / Disclaimer?

0

Is the information pertaining to the RTI officer available on the website?

0

Does the SOE respond to an RTI within the timeframe specified in the Act?

1

Does the SOE have a website?

1

Does the SOE website contain sufficient organtisational details?

1

Does the SOE website contain tender and procurement details?

Annual Report
Accessibility of Information
Auditing Standards
Rights to Information

Interpratation of the indicators

Good
2
Average
1
Bad
0

Financials

Available Financial data for the last few years.

Year Turnover (LKR) Total Assets Profit/Loss Total Debt Total Liabilities Total Equity Operational Profits ROA
2020
7,648,000
Data Not Avalaible 1,164,000 Data Not Avalaible Data Not Avalaible Data Not Avalaible Data Not Avalaible
Data Not Avalaible
2019
5,646,878
Data Not Avalaible 434,777
2,685,049
3,733,598
3,451,788
564,411
12.1
2018
4,621,537
6,229,454
251,262
2,604,320
3,274,177
2,955,277
308,741
5.4
2017
3,174,613
3,073,471
223,908
176,537
331,826
2,741,645
244,782
7.5
2016
2,549,000
2,902,000
262,000 Data Not Avalaible
343,000
2,560,000
262,000
9.4
2015
2,054,363
2,700,885
262,323
179,058
402,008
2,298,877
364,846
10.3

Download our datasets

Access Advocata Institute's Datasets on State Owned Enterprises